Request for Measures of Healthcare Experiences of People With Mobility Impairment, 13504-13506 [05-5436]
Download as PDF
13504
Federal Register / Vol. 70, No. 53 / Monday, March 21, 2005 / Notices
SUMMARY: The General Services
Administration (GSA) announces its
intent to prepare an Environmental
Impact Statement (EIS) under the
National Environmental Policy Act
(NEPA) of 1969 to assess the potential
impacts of the construction of a New
Border Station Facility on Interstate 91
in Derby Line, Vermont (the ‘‘Proposed
Action’’).
At the request of the US Customs and
Border Protection, the GSA is proposing
to construct a new border station facility
on Interstate Highway 91 at Derby Line,
Vermont. The existing facilities are
undersized and obsolete, and
consequently incapable of providing the
level of security now required.
The Proposed Action has been
defined and will likely include: (a)
identification of land requirements,
including acquisition of adjoining land
if appropriate; (b) demolition of all
existing government structures at the
border station; (c) construction of a
main administration building and
ancillary support buildings; and (d)
relocation a portion of the I–91 roadway
and interchange and consequent
potential alterations to secondary roads.
The location of the new border station
facility is set by the requirement that the
facility be located at the intersection of
the interstate highway and the U. S.
Border. Therefore, alternatives to be
studied will identify alternative
locations for the components of the
border station including the main
administration and ancillary support
buildings, the roadway and interchange.
A No Action alternative will also be
studied that will evaluate the
consequences of not constructing the
new border station facility. This
alternative is included to provide a basis
for comparison to the action alternatives
described above as required by NEPA
regulations (40 CFR 1002.14(d)).
GSA invites individuals,
organizations and agencies to submit
comments concerning the scope of the
EIS.
The public scoping period starts with
the publication of this notice in the
Federal Register and will continue for
forty five (45) days from the date of this
notice. GSA will consider all comments
received or postmarked by that date in
defining the scope of the EIS.
GSA expects to issue a Draft EIS in
summer 2005 at which time its
availability will be announced in the
Federal Register and local media. A
public comment period will commence
upon publication of the Notice of
Availability. The GSA will consider and
respond to comments received on the
Draft EIS in preparing the Final EIS.
VerDate jul<14>2003
18:36 Mar 18, 2005
Jkt 205001
Written comments or
suggestions concerning the scope of the
EIS should be sent to David M.
Drevinsky P.E., PMP, Regional
Environmental Quality Advocate
(REQA), U.S. General Services
Administration, 10 Causeway Street,
Room 975, Boston, MA 02222; Fax (617)
565–5967.
FOR FURTHER INFORMATION CONTACT:
David M. Drevinsky by phone at (617)
565–6596 or by email at
dave.drevinsky@gsa.gov.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Other Agency Involvement:
The GSA anticipates that the Federal
Highway Administration will be a
cooperating agency in the preparation of
the EIS because the proposed action
affects the Federal Highway System.
The GSA will consult with the Vermont
Agency of Transportation regarding
regulatory issues pertaining to the
Proposed Action.
Public Scoping Meetings:
A public scoping meeting will
provide the public with an opportunity
to present comments, ask questions, and
discuss concerns regarding the scope of
the EIS for the Proposed Action with
GSA representatives. GSA will hold a
public scoping meeting in April 2005 at
Derby Line, Vermont. Once established,
the specific date for this meeting will be
published in the Federal Register and
the local media.
Date: March 14, 2005
Dennis R. Smith
Regional Administrator,New England Region
[FR Doc. 05–5452 Filed 3–18–05; 8:45 am]
BILLING CODE 6820–23–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Request for Measures of Healthcare
Experiences of People With Mobility
Impairment
Agency for Healthcare Research
and Quality (AHRQ), DHHS.
ACTION: Notice of request for measures.
AGENCY:
SUMMARY: The Agency for Healthcare
Research and Quality (AHRQ), with the
support of the Centers for Disease
Control and Prevention (CDC) of the
U.S. Department of Health and Human
Services and the National Institute on
Disability and Rehabilitation Research
(NIDRR) of the U.S. Department of
Education are soliciting the submission
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
of instruments or items that measure the
quality of healthcare experienced by
people with mobility impairment. The
instruments or items will be considered
for inclusion in a CAHPS survey of
people with mobility impairment
(PWMI). Items or survey instruments
may be submitted from researchers,
health plans, other health care
providers, disability organizations,
stakeholders, vendors and other
interested parties. This initiative is in
response to suggestions from a
significant number of stakeholders to
develop a CAHPS tool that measures
the quality of care as perceived by
adults with disabilities, and to provide
performance data to health plans and
others that are actionable for quality
improvement and access. Our response
to stakeholder requests will ultimately
provide users with a flexible survey tool
to assess the quality of healthcare
services for adults with disabilities
across multiple settings. The focus of
this initial project will be only on
people with mobility impairments, and
subsequent survey projects may focus
on other aspects of disability.
Many questions in the existing
CAHPS instruments address concerns of
people with mobility impairments,
including access, communication,
courtesy and respect, and shared
decision-making. We are particularly
interested in identifying and
considering new content areas, new
response categories and scales for
existing questions, and revised wording
or question order to make existing
questions disability-appropriate.
DATES: Please submit instruments or
items and supporting information on or
before May 20, 2005. AHRQ will not
respond individually to submitters, but
will consider all submitted instruments
and items, and publicly report the
results of the review of the submissions
in aggregate.
ADDRESSES: Submissions should include
a brief cover letter, a copy of an
instrument or items for consideration,
and supporting statements and
information as specified under the
submission criteria below. Submissions
may be in the form of a letter or e-mail,
preferably as an electronic file with an
e-mail attachment. Electronic
submissions are strongly encouraged.
Responses to this request should be
submitted to: Marybeth Farquhar, RN,
MSN, Agency for Healthcare Research
and Quality, 540 Gaither Road,
Rockville, MD 20850, phone: (301) 427–
1317, Fax: (301) 427–1341, e-mail:
mfarquha@ahrq.gov.
To facilitate handling of submissions,
please include full-information about
E:\FR\FM\21MRN1.SGM
21MRN1
Federal Register / Vol. 70, No. 53 / Monday, March 21, 2005 / Notices
the instrument developer or contact
person: (a) Name, (b) title, (c)
organization, (d) mailing address, (e)
telephone number, (f) fax number, and
(g) e-mail address. Also, please submit
with a copy of the instrument or items
for consideration, evidence that it/they
meet(s) the criteria set out under the
Submission Criteria section below.
Please do not use acronyms in your
submissions.
Submitters musts also provide a
statement of willingness to grant to
AHRQ the right to use and authorize
others to use submitted measures and
their documentation as part of a new or
revised CAHPS-trademarked
instrument. The new CAHPS
instrument for people with mobility
impairments will be made publicly
available, free of charge.
FOR FURTHER INFORMATION CONTACT:
Marybeth Farquhar, RN, MSN, Center
for Quality Improvement and Patient
Safety, Agency for Healthcare Research
and Quality, 540 Gaither Road,
Rockville, MD 20850; phone (301) 427–
1317; Fax: (301) 427–1341; e-mail:
mfarquha@ahrq.gov.
Submission Criteria
Instruments submitted should focus
on health care for the functions listed
below, as well as any other quality
domains that are indicated by the field
to be important for people with mobility
impairments. The following are
provided as examples of areas of
interest; however, items or tools
reflecting additional domains are also
welcome.
• Care coordination between
providers or sites of care for people with
mobility impairments;
• Shared decision-making or
consumer involvement in decisionmaking about health care options and
treatment.
• Culturally appropriate and
disability sensitive care or care that tries
to meet the cultural and linguistic needs
of consumers including those using
augmentative communication devices.
• Availability of information from the
health plan in suitable alternative
formats to promote consumer decisionmaking about health care options,
treatment and access;
• Availability and usability of planlevel information in alternative formats
on benefits, coverage, out-of-pocket cost
to consumers, and how to file
grievances/appeals;
• Availability and usability of
consumer information from the health
plan that identifies and compares
accessible and disability-literate
providers;
VerDate jul<14>2003
18:36 Mar 18, 2005
Jkt 205001
• Availability and usability of
consumer information from the health
plan to assist consumers in the selection
of individual clinician (primary care or
specialist) or treatment programs (e.g.,
pain management, skin breakdown
clinics, or condition-sepcific clinics
such as multiple sclerosis or post-polio);
and,
• Helpfulness of health plan call
center staff and customer service staff.
Measures submitted should meet
these criteria to be considered: Capture
the quality of care as experienced by
people with mobility impairments;
demonstrate a high degree of reliability
and validity across different conditions
leading to different degrees of mobility
impairment; and have been used
widely, not just in one or two research
studies.
Submitter’s willingness to grant to
AHRQ the right to use and authorize
others to use the instrument means that
the CAHPS trademark will be applied
to a new instrument combining the best
features of all the submissions as well
as any ideas that may be developed in
the course of reviewing them. Free
access to any final CAHPS instrument(s)
for people with mobility impairment,
and free access to the instrument’s
supportive/administrative information
is important to permit widespread use
of a uniform tool. Thus, submitters of
items that may be incorporated in the
new CAHPS-PWMI supplement will be
required to permit such universal free
access to and use of, their incorporated
item(s). However, item ownership will
be protected during testing of the new
CAHPS-PWMI surveys. AHRQ, in
collaboration with NIDRR, CDC, and the
expert CAHPS grantees, will evaluate all
submitted instruments or items, and
select one or more either in whole or in
part for testing and, if required,
modification. AHRQ will assume
responsibility for the final instruments
as well as any future modifications.
The final instruments will bear the
CAHPS trademark and they will be
made freely available for use by all
interested parties. Submitters will
relinquish exclusive control of any
items that appear in the final
instrument. As a matter of quality
control there will be warnings that
CAHPS identification may not be used
if any changes are made to the
instrument or final measure set without
review and permission of the Agency.
Each submission should include the
following information:
• The name of the instrument;
• Whether the instrument/item(s) is
disease or condition specific;
• Domain(s) of the instrument/items;
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
13505
• Language(s) in which the
instrument/item(s) is available;
• Evidence of cultural/cross group
comparability, if any;
• Instrument reliability (internal
consistency, test-retest, etc.);
• Validity (content, construct,
criterion-related);
• Response rates;
• Methods and results of cognitive
testing and field-testing;
• Description of sampling strategies
and data collection protocols, including
such elements as mode of
administration, use of advance letters,
timing and frequencies of contacts;
• A list of where the instrument has
been fielded and at what level it has
been and/or is being used; and
• Evidence addressing the criteria
should be demonstrated through
submission of peer-reviewed journal
article(s) or through the best evidence
available at the time of submission.
Citation of peer-reviewed journal
article(s) pertaining to the instrument or
item(s) include the title of the article,
author(s), publication year, journal
name, volume, issue, and page numbers
where article appears, may be included
but are not required.
Submission of copies of existing
report formats developed to provide
findings to consumers and providers is
desirable, but not required.
Additionally, information about existing
database(s) for the instrument(s)
submitted is helpful, but also not
required for submission.
SUPPLEMENTARY INFORMATION:
Background
Public and private organizations are
surveying consumers to collect
information on access to care, use of
health services, health outcomes, and
patient satisfaction. The results of these
surveys are being used by: Consumers to
inform their choices about health care
plans; purchasers to assess the value of
the services they buy; and health
insurers, quality managers and policy
makers, to plan programs and services.
The original CAHPS Request for
Applications (RFA) broadly defined the
future direction of the CAHPS initiative
including the development of a core
health plan survey and additional
modules to obtain assessment data from
a variety of consumers including high
users of health care services, such as the
chronically ill, those suffering severe
acute episodes of illness, and persons
with disabilities.
Rationale for developing a CAHPS–
PWMI includes:
• Persons with disabilities on average
need both more health services as well
as more complex services than persons
E:\FR\FM\21MRN1.SGM
21MRN1
13506
Federal Register / Vol. 70, No. 53 / Monday, March 21, 2005 / Notices
without disabilities. It is important for
providers, payers, purchasers and other
stakeholders to understand what these
needs are so that they can be met more
appropriately.
• Information about health plan and
health care deficits ins an important
step in quality improvement for all
consumers. Because they are on average
higher users of care and often use a large
variety of services, persons with
mobility impairments are likely to
identify important plan deficits that
may be evident to consumers without
disabilities.
• More persons with mobility
impairments are being offered complex
choices about both health plan options
and health care quality.
In CAHPS II, we are focusing on a
single type of impairment, specifically
mobility impairments, which can be
used as a starting point for
development. We define ‘‘mobility
impairment’’ as a functional impairment
of the lower limbs. Some health care
needs of people with and without
mobility impairments are similar; for
example, everyone needs preventive
screening services and counseling about
healthy behaviors. Mobility
impairments severe enough to require
an assistive device usually stem from a
condition requiring additional
preventive and specialized health care
needs such as examining tables that can
be adjusted for easy transfer, and
accessible diagnostic equipment and
rest rooms. The mobility impairment
may be accompanied by upper limb
mobility impairments, chronic pain,
impaired cognition, and/or behavioral
co-impairments such as anxiety or
depression. Consequently even though
initially we are directly addressing the
specific needs of people with mobility
impairments, we will also be indirectly
addressing the needs of people with
other types of impairments.
Dated: March 10, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05–5436 Filed 3–18–05; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC–INFO Contact Center;
Announcement
Centers for Disease Control and
Prevention.
ACTION: Public notice.
AGENCY:
VerDate jul<14>2003
18:36 Mar 18, 2005
Jkt 205001
SUMMARY: The Centers for Disease
Control and Prevention announces a
new consolidated consumer response
service for health information inquiries
called the CDC–INFO Contact Center
and is phasing out of numerous existing
hotlines and clearinghouses serving
those purposes.
SUPPLEMENTARY INFORMATION: This
notice is being published pursuant to
The Office of Management and Budget
(OMB) Circular A–130, ‘‘Management of
Federal Information Resources,’’ Section
8.a.6.(j) which requires federal agencies
to provide adequate notice when
initiating, substantially modifying, or
terminating significant information
dissemination products.
CDC is transitioning to a new
consumer response service (CRS)
offering that will consolidate virtually
all of CDC’s existing hotlines,
clearinghouses, and other information
fulfillment services for the public and
health professionals seeking health
information from CDC. Beginning in
February 2005 and extending over the
following 2–3 years, the breadth of
CDC’s health topics will be transitioned
into the new consolidated service.
The CRS will handle incoming calls,
fax transmissions, postal mail, e-mails,
and web inquiries, 24 hours a day, every
day. Responses will be provided
verbally, via fax, e-mail, interactive web,
or postal mail based on the nature of the
information request and the caller’s
preferred response method. The service
will be multilingual (Spanish initially)
and include services for the hearing
impaired.
As the current services are
transitioned, existing hotlines and
clearinghouses will be phased out.
Targeted notifications will be
disseminated to the particular
communities of interest as each health
topic is transitioned. Similarly, the CDC
voice/fax information service, (CDC VIS)
which is an interactive voice response
system will be phased out when the
majority of health topics have been
transitioned.
The overall objective of the CDC–
INFO Contact Center is to ensure the
dissemination of consistent, timely,
reliable health information to a variety
of consumers, and to address variations
in the number of inquiries related to
public health emergencies, news events,
and dynamic, shifting public health
priorities. Specific objectives are to
bring CDC closer to citizens and
improve their ability to access health
information from CDC. The CDC–INFO
Contact Center will provide service at
the first level of contact to give citizens
the health information they want, when
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
they want it, and how they want it. In
addition to optimizing customer
interactions, the CDC–INFO Contact
Center will reduce the unit cost of
providing health information, support
accountability, and employ
performance-based metrics to meet
customer satisfaction goals.
FOR FURTHER INFORMATION CONTACT:
Dottie Knight, CDC, telephone 404–498–
3208 (dsknight@cdc.gov) or Suzi Gates,
CDC, telephone 404–639–7829
(sgates@cdc.gov).
Dated: March 14, 2005.
James Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–5495 Filed 3–18–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Community and Tribal
Subcommittee of the Board of Scientific
Counselors (BSC), National Center for
Environmental Health (NCEH)/Agency
for Toxic Substances and Disease
Registry (ATSDR), Centers for Disease
Control and Prevention (CDC):
Teleconference.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), The Centers for
Disease Control and Prevention, NCEH/
ATSDR announces the following
subcommittee meeting:
Name: Community and Tribal
Subcommittee (CTS).
Time and Date: 3 p.m.–4:30 p.m., April 4,
2005.
Place: The teleconference will originate at
the National Center for Environmental
Health/Agency for Toxic Substances and
Disease Registry in Atlanta, Georgia. Please
see ‘‘Supplementary Information’’ for details
on accessing the teleconference.
Status: Open to the public, teleconference
access limited only by availability of
telephone ports.
Purpose: Under the charge of the Board of
Scientific Counselors, NCEH/ATSDR, the
Community and Tribal Subcommittee will
provide the Board with a forum for
community and tribal first-hand perspectives
on the interactions and impacts of the NCEH/
ATSDR’s national and regional policies,
practices and programs.
Matters to be Discussed: The
teleconference agenda will include
continuing discussions from the last
teleconference of January 8, 2005, on
obtaining directions from the Board on their
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 70, Number 53 (Monday, March 21, 2005)]
[Notices]
[Pages 13504-13506]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5436]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Request for Measures of Healthcare Experiences of People With
Mobility Impairment
AGENCY: Agency for Healthcare Research and Quality (AHRQ), DHHS.
ACTION: Notice of request for measures.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ), with
the support of the Centers for Disease Control and Prevention (CDC) of
the U.S. Department of Health and Human Services and the National
Institute on Disability and Rehabilitation Research (NIDRR) of the U.S.
Department of Education are soliciting the submission of instruments or
items that measure the quality of healthcare experienced by people with
mobility impairment. The instruments or items will be considered for
inclusion in a CAHPS[reg] survey of people with mobility impairment
(PWMI). Items or survey instruments may be submitted from researchers,
health plans, other health care providers, disability organizations,
stakeholders, vendors and other interested parties. This initiative is
in response to suggestions from a significant number of stakeholders to
develop a CAHPS[reg] tool that measures the quality of care as
perceived by adults with disabilities, and to provide performance data
to health plans and others that are actionable for quality improvement
and access. Our response to stakeholder requests will ultimately
provide users with a flexible survey tool to assess the quality of
healthcare services for adults with disabilities across multiple
settings. The focus of this initial project will be only on people with
mobility impairments, and subsequent survey projects may focus on other
aspects of disability.
Many questions in the existing CAHPS instruments address concerns
of people with mobility impairments, including access, communication,
courtesy and respect, and shared decision-making. We are particularly
interested in identifying and considering new content areas, new
response categories and scales for existing questions, and revised
wording or question order to make existing questions disability-
appropriate.
DATES: Please submit instruments or items and supporting information on
or before May 20, 2005. AHRQ will not respond individually to
submitters, but will consider all submitted instruments and items, and
publicly report the results of the review of the submissions in
aggregate.
ADDRESSES: Submissions should include a brief cover letter, a copy of
an instrument or items for consideration, and supporting statements and
information as specified under the submission criteria below.
Submissions may be in the form of a letter or e-mail, preferably as an
electronic file with an e-mail attachment. Electronic submissions are
strongly encouraged. Responses to this request should be submitted to:
Marybeth Farquhar, RN, MSN, Agency for Healthcare Research and Quality,
540 Gaither Road, Rockville, MD 20850, phone: (301) 427-1317, Fax:
(301) 427-1341, e-mail: mfarquha@ahrq.gov.
To facilitate handling of submissions, please include full-
information about
[[Page 13505]]
the instrument developer or contact person: (a) Name, (b) title, (c)
organization, (d) mailing address, (e) telephone number, (f) fax
number, and (g) e-mail address. Also, please submit with a copy of the
instrument or items for consideration, evidence that it/they meet(s)
the criteria set out under the Submission Criteria section below.
Please do not use acronyms in your submissions.
Submitters musts also provide a statement of willingness to grant
to AHRQ the right to use and authorize others to use submitted measures
and their documentation as part of a new or revised CAHPS[reg]-
trademarked instrument. The new CAHPS[reg] instrument for people with
mobility impairments will be made publicly available, free of charge.
FOR FURTHER INFORMATION CONTACT: Marybeth Farquhar, RN, MSN, Center for
Quality Improvement and Patient Safety, Agency for Healthcare Research
and Quality, 540 Gaither Road, Rockville, MD 20850; phone (301) 427-
1317; Fax: (301) 427-1341; e-mail: mfarquha@ahrq.gov.
Submission Criteria
Instruments submitted should focus on health care for the functions
listed below, as well as any other quality domains that are indicated
by the field to be important for people with mobility impairments. The
following are provided as examples of areas of interest; however, items
or tools reflecting additional domains are also welcome.
Care coordination between providers or sites of care for
people with mobility impairments;
Shared decision-making or consumer involvement in
decision-making about health care options and treatment.
Culturally appropriate and disability sensitive care or
care that tries to meet the cultural and linguistic needs of consumers
including those using augmentative communication devices.
Availability of information from the health plan in
suitable alternative formats to promote consumer decision-making about
health care options, treatment and access;
Availability and usability of plan-level information in
alternative formats on benefits, coverage, out-of-pocket cost to
consumers, and how to file grievances/appeals;
Availability and usability of consumer information from
the health plan that identifies and compares accessible and disability-
literate providers;
Availability and usability of consumer information from
the health plan to assist consumers in the selection of individual
clinician (primary care or specialist) or treatment programs (e.g.,
pain management, skin breakdown clinics, or condition-sepcific clinics
such as multiple sclerosis or post-polio); and,
Helpfulness of health plan call center staff and customer
service staff.
Measures submitted should meet these criteria to be considered:
Capture the quality of care as experienced by people with mobility
impairments; demonstrate a high degree of reliability and validity
across different conditions leading to different degrees of mobility
impairment; and have been used widely, not just in one or two research
studies.
Submitter's willingness to grant to AHRQ the right to use and
authorize others to use the instrument means that the CAHPS[reg]
trademark will be applied to a new instrument combining the best
features of all the submissions as well as any ideas that may be
developed in the course of reviewing them. Free access to any final
CAHPS instrument(s) for people with mobility impairment, and free
access to the instrument's supportive/administrative information is
important to permit widespread use of a uniform tool. Thus, submitters
of items that may be incorporated in the new CAHPS-PWMI supplement will
be required to permit such universal free access to and use of, their
incorporated item(s). However, item ownership will be protected during
testing of the new CAHPS-PWMI surveys. AHRQ, in collaboration with
NIDRR, CDC, and the expert CAHPS grantees, will evaluate all submitted
instruments or items, and select one or more either in whole or in part
for testing and, if required, modification. AHRQ will assume
responsibility for the final instruments as well as any future
modifications.
The final instruments will bear the CAHPS[reg] trademark and they
will be made freely available for use by all interested parties.
Submitters will relinquish exclusive control of any items that appear
in the final instrument. As a matter of quality control there will be
warnings that CAHPS[reg] identification may not be used if any changes
are made to the instrument or final measure set without review and
permission of the Agency.
Each submission should include the following information:
The name of the instrument;
Whether the instrument/item(s) is disease or condition
specific;
Domain(s) of the instrument/items;
Language(s) in which the instrument/item(s) is available;
Evidence of cultural/cross group comparability, if any;
Instrument reliability (internal consistency, test-retest,
etc.);
Validity (content, construct, criterion-related);
Response rates;
Methods and results of cognitive testing and field-
testing;
Description of sampling strategies and data collection
protocols, including such elements as mode of administration, use of
advance letters, timing and frequencies of contacts;
A list of where the instrument has been fielded and at
what level it has been and/or is being used; and
Evidence addressing the criteria should be demonstrated
through submission of peer-reviewed journal article(s) or through the
best evidence available at the time of submission. Citation of peer-
reviewed journal article(s) pertaining to the instrument or item(s)
include the title of the article, author(s), publication year, journal
name, volume, issue, and page numbers where article appears, may be
included but are not required.
Submission of copies of existing report formats developed to
provide findings to consumers and providers is desirable, but not
required. Additionally, information about existing database(s) for the
instrument(s) submitted is helpful, but also not required for
submission.
SUPPLEMENTARY INFORMATION:
Background
Public and private organizations are surveying consumers to collect
information on access to care, use of health services, health outcomes,
and patient satisfaction. The results of these surveys are being used
by: Consumers to inform their choices about health care plans;
purchasers to assess the value of the services they buy; and health
insurers, quality managers and policy makers, to plan programs and
services. The original CAHPS Request for Applications (RFA) broadly
defined the future direction of the CAHPS initiative including the
development of a core health plan survey and additional modules to
obtain assessment data from a variety of consumers including high users
of health care services, such as the chronically ill, those suffering
severe acute episodes of illness, and persons with disabilities.
Rationale for developing a CAHPS-PWMI includes:
Persons with disabilities on average need both more health
services as well as more complex services than persons
[[Page 13506]]
without disabilities. It is important for providers, payers, purchasers
and other stakeholders to understand what these needs are so that they
can be met more appropriately.
Information about health plan and health care deficits ins
an important step in quality improvement for all consumers. Because
they are on average higher users of care and often use a large variety
of services, persons with mobility impairments are likely to identify
important plan deficits that may be evident to consumers without
disabilities.
More persons with mobility impairments are being offered
complex choices about both health plan options and health care quality.
In CAHPS II, we are focusing on a single type of impairment,
specifically mobility impairments, which can be used as a starting
point for development. We define ``mobility impairment'' as a
functional impairment of the lower limbs. Some health care needs of
people with and without mobility impairments are similar; for example,
everyone needs preventive screening services and counseling about
healthy behaviors. Mobility impairments severe enough to require an
assistive device usually stem from a condition requiring additional
preventive and specialized health care needs such as examining tables
that can be adjusted for easy transfer, and accessible diagnostic
equipment and rest rooms. The mobility impairment may be accompanied by
upper limb mobility impairments, chronic pain, impaired cognition, and/
or behavioral co-impairments such as anxiety or depression.
Consequently even though initially we are directly addressing the
specific needs of people with mobility impairments, we will also be
indirectly addressing the needs of people with other types of
impairments.
Dated: March 10, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-5436 Filed 3-18-05; 8:45 am]
BILLING CODE 4160-90-M